Document Detail


Progress in phototherapy.
MedLine Citation:
PMID:  9077024     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this article is to present a recent advance in phototherapy employed on newborn babies with jaundice. The efficacy of this treatment depends on the intensity of emitted light; it is believed that a dose between 6-12 nm is necessary. The usefulness of phototherapy in healthy, full-term infants is currently being questioned. Therefore, the adequate use of this therapy should be emphasized until a consensus is reached on its advantages and disadvantages.
Authors:
M C de Araújo; F A Vaz; J L Ramos
Related Documents :
12493074 - Association of lipid peroxidation with hepatocellular injury in preterm infants.
15730604 - Does gender affect neonatal hyperbilirubinemia in low-birth-weight infants?
11370434 - Neonatal jaundice in very low birth weight babies.
15578034 - Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dys...
6326414 - Evidence of prolactin receptors in the choroid plexus and a possible role in water bala...
19501444 - Electrophysiological markers of categorical perception of color in 7-month old infants.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  São Paulo medical journal = Revista paulista de medicina     Volume:  114     ISSN:  1516-3180     ISO Abbreviation:  Sao Paulo Med J     Publication Date:    1996 Mar-Apr
Date Detail:
Created Date:  1997-05-22     Completed Date:  1997-05-22     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100897261     Medline TA:  Sao Paulo Med J     Country:  BRAZIL    
Other Details:
Languages:  eng     Pagination:  1134-40     Citation Subset:  IM    
Affiliation:
University of São Paulo Medical School, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bilirubin / blood
Birth Weight
Humans
Infant, Newborn
Jaundice, Neonatal / blood,  therapy*
Phototherapy* / instrumentation,  methods
Treatment Outcome
Chemical
Reg. No./Substance:
635-65-4/Bilirubin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A t(9;11) translocation in childhood acute mixed leukemia.
Next Document:  Direct immunofluorescence in lupus erythematosus (LE).